30-day average of 7 articles Β· scale β100 to +100
Across 7 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Northrop Grumman news is Bullish (+68)
on a scale from β100 to +100.
That is up 65 points from the previous 30 days (+3).
π» Emerging technology focus areas include microelectronics and quantum computing for defense applications.
βοΈ The outlook assumes a continuing federal funding resolution extending into early 2027 to ensure program continuity.
π Stock traded at 496.20 euros on November 12, 2026, reflecting investor interest in the growth path.
π Bullish signals
πNorthrop Grumman expects sales to grow by 5% to 7% in 2027 with further momentum into 2028.
πInternational sales are projected to exceed $10 billion by 2031, representing a significant expansion from the current $4.3 billion year-to-date level.
π°οΈNational security space now accounts for more than 15% of company sales, driven by rising demand for communications and resilient space systems.
πKey products like IBCS are growing at double-digit rates and are expected to contribute meaningfully to revenue in 2027.
πManagement highlights durable demand across the defense portfolio, providing a strong foundation for sustained growth.
Article
Northrop Grumman management presented a strengthened long-term growth outlook at the Baird Global Industrial Conference, highlighting durable demand across its defense portfolio and significant international expansion opportunities. CEO Kathy Warden emphasized that the company is well-positioned to capitalize on rising needs in national security space systems, munitions, and integrated air and missile defense technologies.
Specific financial guidance indicates sales growth of 5% to 7% for 2027, with momentum expected to continue into 2028. This outlook relies on a continuing federal funding resolution extending into early 2027 to avoid major program disruptions. International sales, currently around $4.3 billion year-to-date, are projected to exceed $10 billion by 2031.
Key growth drivers include double-digit growth in products like the IBCS system and contributions from future programs such as the B-21 bomber and Sentinel missile program. The company plans to maintain capital spending at approximately 4.5% of sales in 2027 and 2028 to expand capacity, with a potential return to 3% of sales once capacity is established, which could drive future cash flow improvements.
National security space already accounts for more than 15% of total company sales, benefiting from demand for communications, sensing, and resilient space systems. The firm also sees longer-term opportunities in microelectronics and quantum computing, reinforcing its strategic focus on high-growth defense sectors.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Northrop Grumman management presented a strengthened long-term growth outlook at the Baird Global Industrial Conference, highlighting durable demand across its defense portfolio and significant international expansion opportunities. CEO Kathy Warden emphasized that the company is well-positioned to capitalize on rising needs in national security space systems, munitions, and integrated air and missile defense technologies.
Specific financial guidance indicates sales growth of 5% to 7% for 2027, with momentum expected to continue into 2028. This outlook relies on a continuing federal funding resolution extending into early 2027 to avoid major program disruptions. International sales, currently around $4.3 billion year-to-date, are projected to exceed $10 billion by 2031.
Key growth drivers include double-digit growth in products like the IBCS system and contributions from future programs such as the B-21 bomber and Sentinel missile program. The company plans to maintain capital spending at approximately 4.5% of sales in 2027 and 2028 to expand capacity, with a potential return to 3% of sales once capacity is established, which could drive future cash flow improvements.
National security space already accounts for more than 15% of total company sales, benefiting from demand for communications, sensing, and resilient space systems. The firm also sees longer-term opportunities in microelectronics and quantum computing, reinforcing its strategic focus on high-growth defense sectors.
π Northrop Grumman expects 5-7% sales growth through 2028.
π International sales projected to exceed $10 billion by 2031.
π°οΈ National security space now represents over 15% of sales.
π° Capital spending planned at 4.5% of sales in 2027-2028.
π« Growth driven by munitions, counter-drone tech, and missile defense.
π Northrop Grumman expects sales growth of 5% to 7% in 2027 with further momentum into 2028.
π International sales are projected to exceed $10 billion by 2031, up from approximately $4.3 billion year-to-date.
π°οΈ National security space now represents more than 15% of company sales due to rising demand for resilient systems.
π° Capital spending is planned at about 4.5% of sales in 2027 and 2028 to expand manufacturing capacity.
π« Key growth drivers include munitions, counter-drone technology, and integrated air and missile defense systems.
π Products like IBCS are growing at double-digit rates and expected to contribute significantly to 2027 revenue.
π» Emerging technology focus areas include microelectronics and quantum computing for defense applications.
βοΈ The outlook assumes a continuing federal funding resolution extending into early 2027 to ensure program continuity.
π Stock traded at 496.20 euros on November 12, 2026, reflecting investor interest in the growth path.
Bullish Signals
Sales expected to grow 5%-7% by 2027.
International sales projected to exceed $10B by 2031.
National security space now accounts for >15% of sales.
Key products like IBCS growing at double-digit rates.
Secured long-term opportunities in B-21 and Sentinel programs.
Bullish Signals
Northrop Grumman expects sales to grow by 5% to 7% in 2027 with further momentum into 2028.
International sales are projected to exceed $10 billion by 2031, representing a significant expansion from the current $4.3 billion year-to-date level.
National security space now accounts for more than 15% of company sales, driven by rising demand for communications and resilient space systems.
Key products like IBCS are growing at double-digit rates and are expected to contribute meaningfully to revenue in 2027.
The company has secured long-term opportunities in major programs including the B-21 bomber and Sentinel missile system.
Management highlights durable demand across the defense portfolio, providing a strong foundation for sustained growth.
Northrop Grumman is scheduled to present at the Baird 2026 Global Industrial Conference on November 11, with CEO Kathy Warden set to speak. This appearance follows the company's third-quarter earnings release on October 20, which highlighted strong financial performance and a robust order book for its defense and aerospace programs.
The company reported third-quarter sales of $11.122 billion, representing a 7 percent year-over-year increase. Net earnings reached $1.124 billion, with diluted earnings per share rising to $7.89. Additionally, the firm disclosed net awards totaling $16.4 billion and a total backlog of $109.597 billion as of September 30, 2026.
Northrop Grumman raised its full-year 2026 segment operating income guidance to between $4.940 billion and $5.040 billion. The company also lifted its mark-to-market-adjusted earnings-per-share outlook to a range of $29.35 to $29.75, while maintaining its sales forecast between $43.750 billion and $44.250 billion for the year.
π CEO Kathy Warden presents at Baird 2026 Global Industrial Conference on November 11.
π° Q3 sales hit $11.122 billion, a 7% increase from last year.
π Net earnings reached $1.124 billion with diluted EPS of $7.89.
π‘οΈ Record backlog stands at $109.597 billion with $16.4 billion in net awards.
π Raised 2026 operating income guidance to $4.940-$5.040 billion and EPS outlook to $29.35-$29.75.
π Northrop Grumman CEO Kathy Warden is scheduled to present at the Baird 2026 Global Industrial Conference on November 11.
π° Third-quarter sales reached $11.122 billion, marking a 7 percent increase compared to the same period last year.
π Net earnings for the quarter totaled $1.124 billion, with diluted earnings per share climbing to $7.89.
π‘οΈ The company reported a record backlog of $109.597 billion and net awards of $16.4 billion as of September 30, 2026.
π Northrop Grumman raised its 2026 segment operating income guidance to a range of $4.940 billion to $5.040 billion.
πΉ The company lifted its mark-to-market-adjusted earnings-per-share outlook to between $29.35 and $29.75 for the year.
Bullish Signals
Q3 sales rose 7% to $11.122 billion.
Bullish Signals
Northrop Grumman reported a 7 percent year-over-year increase in third-quarter sales, reaching $11.122 billion.
The company achieved record backlog levels of $109.597 billion and secured net awards totaling $16.4 billion in the third quarter.
Northrop Grumman raised its 2026 segment operating income guidance to a range of $4.940 billion to $5.040 billion.
The company lifted its mark-to-market-adjusted earnings-per-share outlook to between $29.35 and $29.75 for the full year.
Northrop Grumman reported robust third-quarter results, driving a significant increase in its backlog to a record $109.6 billion as of September 30, 2026. The company posted third-quarter sales of $11.122 billion, representing a 7% year-over-year increase, with contributions from all four operating sectors including Aeronautics Systems and Defense Systems.
The defense contractor raised its full-year 2026 outlook for segment operating income to between $4.940 billion and $5.040 billion, while also increasing its MTM-adjusted EPS guidance range to $29.35 to $29.75. Despite the margin compression in the quarter due to a prior-year contract adjustment, net earnings rose 2% to $1.124 billion, reflecting strong underlying demand for its aerospace and defense capabilities.
CEO Kathy Warden highlighted that the record backlog and strategic investments support durable future growth, though the company noted exposure to government budgets and supply-chain constraints. The stock traded at 472.15 euros on November 4, 2026, as investors reacted positively to the upgraded profit guidance and the substantial new awards for programs like Sentinel and the F-35.
π Raised 2026 operating income guidance to $4.94B-$5.04B.
π° Q3 sales grew 7% YoY to $11.122B on F-35/B-21 volumes.
π¦ Backlog hit record $109.6B with $16.4B net awards.
πΉ EPS rose to $7.89 as net earnings increased 2%.
π Book-to-bill ratio reached 1.5x showing strong order intake.
π Northrop Grumman raised its 2026 segment operating income guidance to $4.940-$5.040 billion, up from the previous range of $4.850-$5.000 billion.
π° Third-quarter sales reached $11.122 billion, a 7% year-over-year increase driven by higher volumes in F-35, B-21, and B-2 sustainment programs.
π¦ The company's backlog hit a record $109.6 billion on September 30, fueled by net awards of $16.4 billion in the quarter.
π‘οΈ Major new contracts included $2.0 billion for the Sentinel program and $1.4 billion for Virginia-class submarines.
πΉ Diluted earnings per share increased to $7.89 from $7.67, with net earnings rising 2% to $1.124 billion.
π Segment operating margin eased slightly to 12.1% from 12.3%, partially offset by a favorable prior-year contract adjustment.
π The book-to-bill ratio stood at 1.5 times, indicating strong order intake relative to current sales.
Bullish Signals
Raised 2026 operating income guidance to $4.94B-$5.04B.
Risk Factors
Segment margin dropped to 12.1% from 12.3%.
Results face risks from budgets, inflation, and supply chains.
Bullish Signals
Northrop Grumman raised its 2026 segment operating income guidance to $4.940-$5.040 billion, signaling confidence in converting its record backlog into revenue.
The company achieved a record backlog of $109.6 billion with net awards of $16.4 billion in the quarter, providing a durable pipeline for future earnings.
Third-quarter sales grew 7% year-over-year to $11.122 billion, driven by sustained demand across Aeronautics Systems and Defense Systems sectors.
Net earnings increased 2% to $1.124 billion and diluted EPS rose to $7.89, demonstrating solid profitability despite margin headwinds.
Risk Factors
Segment operating margin decreased to 12.1% from 12.3%, though the company attributed part of this decline to a favorable contract adjustment in the prior year.
Future results remain exposed to government budget fluctuations, procurement priorities, inflation, and supply-chain constraints as noted by management.
Northrop Grumman reported a strong third quarter with sales rising 7 percent year over year to $11.1 billion, driven by growth across all four operating sectors including Aeronautics Systems and Defense Systems.
The company achieved a record backlog of $109.6 billion following net awards of $16.4 billion in the quarter, resulting in a 1.5 book-to-bill ratio that strengthens long-term revenue visibility for major programs like the F-35 and Virginia-class submarines.
Management raised its full-year 2026 guidance for segment operating income to a range of $4.94 billion to $5.04 billion and adjusted earnings per share to $29.35 to $29.75, reflecting improved operating performance despite higher corporate costs and interest expenses.
While the sales outlook remains unchanged at $43.75 billion to $44.25 billion, Northrop Grumman highlighted that lower tax rates contributed to the higher profit guidance, with adjusted free cash flow expectations staying between $3.1 billion and $3.5 billion.
π Q3 sales rose 7% to $11.1 billion with record $109.6 billion backlog.
π Aeronautics revenue grew 14% while Defense Systems advanced 12%.
π° EPS increased to $7.89 and 2026 guidance raised to $29.35β$29.75.
ποΈ Major wins include Sentinel, Virginia-class subs, and E-2 aircraft contracts.
π΅ Maintained sales outlook of $43.75β$44.25 billion with steady free cash flow.
π Third-quarter sales increased 7 percent year over year to reach $11.1 billion.
π¦ Net awards of $16.4 billion pushed the total backlog to a record $109.6 billion.
π Aeronautics Systems revenue grew 14 percent while Defense Systems advanced 12 percent.
π° Diluted earnings per share rose to $7.89 from $7.67 in the prior year.
π Management raised 2026 segment operating income guidance to $4.94 billionβ$5.04 billion.
π Adjusted earnings per share guidance for 2026 was increased to $29.35β$29.75.
π΅ The company maintained its sales outlook between $43.75 billion and $44.25 billion.
π° Adjusted free cash flow guidance remains steady at $3.1 billion to $3.5 billion.
ποΈ Major contract wins include restricted programs, Sentinel, Virginia-class submarines, and E-2 aircraft.
βοΈ Higher profit outlook is attributed to stronger operations and a lower tax rate.
Bullish Signals
Backlog hit record $109.6B with $16.4B net awards.
Bullish Signals
Northrop Grumman achieved record backlog of $109.6 billion following $16.4 billion in net awards, securing long-term revenue visibility.
Third-quarter sales grew 7 percent year over year to $11.1 billion with double-digit growth in Aeronautics Systems and Defense Systems.
Management raised 2026 segment operating income guidance to $4.94 billionβ$5.04 billion, reflecting stronger operational performance.
Adjusted earnings per share guidance for 2026 was increased to $29.35β$29.75, demonstrating improved profitability expectations.
The company maintained its sales outlook while upgrading profit guidance, indicating confidence in execution and margin expansion.
Northrop Grumman reported robust third-quarter financial results, with sales rising 7 percent year over year to USD 11.1 billion. This growth was primarily driven by strong performance in its Aeronautics Systems and Defense Systems sectors, which saw increases of 14 percent and 12 percent respectively. The company also achieved record net awards totaling USD 16.4 billion, pushing its total backlog to a historic high of USD 109.6 billion as of September 30.
Beyond top-line revenue, the company demonstrated improved profitability metrics despite a slight narrowing in overall operating margin. Operating income increased by 2 percent to USD 1.27 billion, while segment operating income rose 5 percent to USD 1.35 billion. Diluted earnings per share climbed to USD 7.89, and adjusted free cash flow surged 44 percent to USD 1.81 billion, aided by operational efficiency and asset sales.
Following the earnings release, Northrop Grumman management raised its full-year 2026 guidance for both segment operating income and MTM-adjusted earnings per share. The company reaffirmed its sales outlook while maintaining its free cash flow projection. CEO Kathy Warden highlighted that the record backlog and strategic portfolio positioning are expected to sustain future growth, though investors remain focused on execution risks in complex fixed-price programs.
π Q3 sales rose 7% to $11.1B driven by aerospace and defense demand.
π Net awards hit record $16.4B, expanding backlog to $109.6B.
βοΈ Aeronautics Systems revenue grew 14% to $3.575B leading segment growth.
π° EPS increased to $7.89 with adjusted free cash flow up 44%.
π Management raised 2026 operating income and MTM-adjusted EPS guidance.
π Northrop Grumman third-quarter sales increased 7 percent year over year to USD 11.1 billion, driven by strong demand in aerospace and defense.
π Net awards reached a record USD 16.4 billion, expanding the total backlog to USD 109.6 billion as of September 30.
βοΈ Aeronautics Systems led revenue growth with a 14 percent increase to USD 3.575 billion, followed by Defense Systems at 12 percent.
π° Operating income rose 2 percent to USD 1.269 billion, while segment operating income grew 5 percent to USD 1.345 billion.
π The overall operating margin narrowed slightly to 11.4 percent from 11.9 percent due to mix and program execution factors.
π΅ Diluted earnings per share increased to USD 7.89, reflecting improved profitability across the business segments.
π§ Adjusted free cash flow jumped 44 percent to USD 1.81 billion, supported by higher operating cash flow and equipment sales.
π Management raised its 2026 segment operating income guidance midpoint by USD 65 million to a range of USD 4.94-5.04 billion.
πΉ MTM-adjusted EPS guidance was increased to a range of USD 29.35-29.75, up from the previous forecast.
π‘οΈ Key growth drivers include restricted programs, Sentinel, Virginia-class submarines, F-35 work, and E-2 aircraft orders.
β οΈ Investors are monitoring execution on complex fixed-price programs and government funding timelines for delivery schedules.
π Northrop Grumman stock traded at 496.70 euros on the Lang & Schwarz exchange as of November 2, 2026.
Bullish Signals
Q3 sales up 7% to $11.1B.
Net awards hit record $16.4B.
Operating income grew 5% to $1.345B.
Free cash flow surged 44% to $1.81B.
Raised full-year guidance by $65M.
Risk Factors
Operating margin narrowed to 11.4% from 11.9%.
Delivery depends on complex execution and funding.
Bullish Signals
Northrop Grumman reported a 7 percent year-over-year increase in third-quarter sales to USD 11.1 billion, demonstrating strong demand for its aerospace and defense programs.
The company achieved record net awards of USD 16.4 billion, expanding its backlog to a historic USD 109.6 billion which provides long-term revenue visibility.
Segment operating income grew 5 percent to USD 1.345 billion, driven by higher sales in Aeronautics Systems and improved performance across the portfolio.
Adjusted free cash flow surged 44 percent to USD 1.81 billion, indicating strong balance sheet health and operational efficiency.
Management raised its full-year 2026 segment operating income guidance by USD 65 million at the midpoint, signaling confidence in future earnings.
MTM-adjusted EPS guidance was increased to a range of USD 29.35-29.75, reflecting positive outlook for profitability despite margin headwinds.
Third-quarter diluted earnings per share rose to USD 7.89 from USD 7.67 in the prior year period, showing consistent profit growth.
Risk Factors
The overall operating margin narrowed to 11.4 percent from 11.9 percent a year earlier, indicating pressure on profitability despite revenue growth.
Delivery timing for the record backlog remains dependent on complex program execution and government funding availability, introducing potential execution risk.
Northrop Grumman shares rose 2.26% to EUR 499.25 on October 26, 2026, following a strong third-quarter performance reported on October 20. The company posted third-quarter sales of USD 11.12 billion, representing a 7% increase year-over-year, while diluted earnings per share reached USD 7.89 compared to USD 7.67 in the prior year.
The defense contractor significantly expanded its order book, reporting a backlog of USD 109.60 billion as of September 30, 2026, which is up 15% from the previous year-end figure. This substantial growth in contract coverage provides a robust foundation for future revenue streams despite a slight decline in operating margins to 11.40% from 11.90%.
Analyst sentiment remains bullish, with Baird upgrading Northrop Grumman to Outperform and raising its price target to USD 675 on October 21. The company also raised its full-year adjusted earnings guidance to a range of USD 29.35 to USD 29.75 per share, reflecting confidence in its strategic outlook and contract pipeline.
π NOC stock rose 2.26% to EUR 499.25 on October 26, 2026.
π° Q3 sales surged 7% year-over-year to USD 11.12 billion.
π Diluted EPS increased to USD 7.89 from USD 7.67.
π¦ Order backlog expanded 15% to USD 109.60 billion.
π Baird upgraded NOC to Outperform with a USD 675 target.
π Northrop Grumman stock gained 2.26% to EUR 499.25 on October 26, 2026, trading above the Xetra close.
π° Third-quarter sales surged 7% year-over-year to reach USD 11.12 billion in the fiscal period ending September 30, 2026.
π Diluted earnings per share increased to USD 7.89, up from USD 7.67 a year earlier.
π¦ The company's order backlog expanded significantly by 15% to USD 109.60 billion as of September 30, 2026.
π Operating margins declined slightly to 11.40% from 11.90% in the previous year.
π Baird upgraded Northrop Grumman to Outperform and raised its price target to USD 675 on October 21, 2026.
π― The company raised its full-year adjusted earnings guidance to a range of USD 29.35 to USD 29.75 per share.
πΉ Northrop Grumman's market capitalization stood at USD 79.3 billion with a price-to-earnings ratio of 17.62.
Bullish Signals
Q3 sales grew 7% to $11.12B.
Risk Factors
Operating margins declined to 11.40% from 11.90% year-over-year.
Northrop Grumman (NOC) is projecting robust financial performance for the third quarter of 2026, with revenue expected to reach $11.63 billion, representing an 8.9% year-over-year increase. This anticipated growth marks a significant reversal from the flat performance seen in the same quarter last year and follows a strong second quarter where the company reported $10.88 billion in revenue and adjusted EPS of $7.70, which significantly beat consensus estimates.
The company has demonstrated strong execution across its key segments, with Aeronautics Systems sales surging 13% to $3.52 billion in the second quarter. Analysts maintain a moderately bullish stance, citing an average price target of $680.44 against recent trading levels, reflecting confidence in the company's ability to deliver above-consensus earnings despite potential top-line pressures.
Beyond traditional defense contracts, Northrop Grumman is leveraging technological advancements to drive future growth, highlighted by successful autonomous space operations with Starlab and a new long-term eVTOL avionics deal. However, the company faces inherent risks related to its heavy reliance on government contracts, which remain subject to shifting political priorities and geopolitical budget uncertainties that could impact sustained margin expansion.
Looking ahead to 2028, Northrop Grumman projects total revenue of $47.5 billion and earnings of $4.4 billion, requiring a sustained annual revenue growth rate of 5.5%. The successful execution of critical programs like the B-21 bomber and Sentinel missile system remains paramount for maintaining profitability and meeting these ambitious long-term targets.
π° Q2 adjusted EPS hit $7.70, beating consensus by $0.86.
π Aeronautics sales surged 13% to $3.52B in the second quarter.
β οΈ Heavy reliance on government contracts creates budgetary and political risks.
π― Execution on B-21 and Sentinel programs critical for margin expansion.
π Northrop Grumman projects Q3 2026 revenue to reach $11.63 billion, an 8.9% year-over-year increase that reverses the flat performance of the prior year.
π° The company reported adjusted EPS of $7.70 in Q2 2026, significantly outpacing the consensus estimate of $6.84 and demonstrating strong margin performance.
π Aeronautics Systems sales surged 13% to $3.52 billion in the second quarter, highlighting robust demand for advanced defense aircraft systems.
π°οΈ Northrop Grumman successfully completed autonomous rendezvous and docking operations with Starlab Space Stations, enhancing its commercial cargo delivery capabilities.
βοΈ The company secured a long-term eVTOL avionics deal, further diversifying its portfolio beyond traditional government contracts into emerging aerospace markets.
π Analysts maintain an average price target of $680.44, suggesting modest upside potential as the stock recently gained 16.3% despite trading near fair value.
β οΈ The company faces ongoing risks from heavy reliance on government contracts which are subject to shifting political and budgetary priorities.
π Geopolitical budget uncertainties persist as a key risk factor that could impact the sustainability of projected revenue growth in defense sectors.
π― Execution on major programs like the B-21 bomber and Sentinel missile system remains critical for maintaining margin expansion through 2028.
π Northrop Grumman projects $47.5 billion in total revenue by 2028, requiring a sustained annual growth rate of 5.5% to meet long-term targets.
Bullish Signals
Q3 2026 revenue projected at $11.63B, up 8.9% YoY.
Risk Factors
Heavy reliance on government contracts creates inherent risks.
Northrop Grumman is projecting Q3 2026 revenue of $11.63 billion, an 8.9% year-over-year increase that reverses the flat performance seen in the prior year.
The company delivered adjusted EPS of $7.70 in Q2 2026, significantly beating the consensus estimate of $6.84 and demonstrating strong margin expansion.
Aeronautics Systems sales surged 13% to $3.52 billion in the second quarter, indicating robust demand for advanced defense aircraft systems.
Northrop Grumman successfully completed autonomous rendezvous and docking operations with Starlab Space Stations, enhancing its commercial cargo delivery capabilities.
The company secured a long-term eVTOL avionics deal, further diversifying its portfolio beyond traditional government contracts into emerging aerospace markets.
Northrop Grumman recently achieved a 16.3% stock gain, outperforming the broader aerospace and defense sector which rose 9.2% on average.
Analysts maintain an average price target of $680.44, suggesting modest upside potential as the company trades near fair value with sustained confidence.
Risk Factors
The company faces inherent risks related to its heavy reliance on large government contracts which remain subject to shifting political and budgetary priorities.
Geopolitical budget uncertainties persist as a key risk factor that could impact the sustainability of projected revenue growth in defense sectors.
TD Cowen analyst firm lowered its price target for Northrop Grumman (NOC) from USD 590 to USD 540 on October 9, 2026, while maintaining a Hold rating. This adjustment comes ahead of the company's third-quarter earnings report scheduled for October 20, 2026, and reflects concerns regarding execution risks in specific defense programs despite recent revenue growth.
Northrop Grumman reported second-quarter revenue of USD 10.88 billion, representing a 5.1% year-over-year increase to USD 10.35 billion in the prior period. However, net profit declined from USD 1.17 billion to USD 1.09 billion for the quarter ended June 30, 2026, as earnings per share dropped to USD 7.68. The company's stock was trading at EUR 442.65 on October 15, 2026, with a market capitalization of approximately USD 70.4 billion.
Management raised its full-year 2026 sales guidance to between USD 43.75 billion and USD 44.25 billion, while adjusting earnings-per-share guidance to a range of USD 28.60 to USD 29.10. The company's order backlog increased by 17% year over year to reach USD 105.00 billion, with second-half revenue expected to rise by more than USD 700 million. Despite the positive guidance, management explicitly cited cost pressures within the GEM 63XL and Stand-in Attack Weapon programs as key execution challenges for the upcoming quarter.
π TD Cowen cut NOC price target to $540 on Oct 9, 2026, maintaining Hold rating.
π° Q2 revenue rose 5.1% YoY to $10.88B while net profit fell to $1.09B.
π Management raised full-year 2026 sales guidance to $43.75-44.25B and adjusted EPS to $28.60-29.10.
π¦ Order backlog grew 17% YoY to $105B with H2 revenue expected above $700M.
β οΈ Cost pressures in GEM 63XL and Stand-in Attack Weapon programs pose critical execution risks.
π TD Cowen cut its Northrop Grumman price target from USD 590 to USD 540 on October 9, 2026, while keeping a Hold rating.
π° Second-quarter revenue reached USD 10.88 billion, up 5.1% year over year, but net profit fell to USD 1.09 billion from USD 1.17 billion.
π Management raised full-year 2026 sales guidance to USD 43.75-44.25 billion and adjusted EPS guidance to USD 28.60-29.10.
π¦ The company's order backlog grew 17% year over year to USD 105.00 billion, with second-half revenue expected to exceed USD 700 million.
β οΈ Management highlighted cost pressures in the GEM 63XL and Stand-in Attack Weapon programs as critical execution risks for the next results.
π Northrop Grumman is scheduled to report third-quarter earnings on October 20, 2026, before the U.S. market opens.
πΉ The stock traded at EUR 442.65 on October 15, 2026, with a market cap of USD 70.4 billion and a 52-week range of USD 453-774.
Bullish Signals
Raised 2026 sales guidance to $43.75-44.25B.
Order backlog grew 17% YoY to $105B.
H2 revenue expected up >$700M.
Secured $18.8M Army contract on Sept 29.
Risk Factors
TD Cowen cut price target from $590 to $540.
Cost pressures in GEM 63XL and Stand-in Attack Weapon programs.
Bullish Signals
Northrop Grumman raised its full-year 2026 sales guidance to USD 43.75-44.25 billion, signaling strong underlying demand and order flow.
The company's order backlog increased by 17% year over year to reach USD 105.00 billion, providing a robust foundation for future revenue growth.
Second-half revenue is expected to increase by more than USD 700 million, indicating continued momentum in the defense sector.
The company secured an USD 18.8 million U.S. Army contract on September 29, 2026, adding to its pipeline of government work.
Risk Factors
TD Cowen lowered its price target from USD 590 to USD 540 due to concerns over execution risks in specific programs.
Management explicitly cited cost pressures in the GEM 63XL and Stand-in Attack Weapon programs as key risks that could impact future profitability.
Northrop Grumman is currently trading at a price-to-earnings multiple of 15.23 as of October 13, 2026, with a market capitalization of USD 68.3 billion. The defense contractor's valuation places it below peers Lockheed Martin and RTX in terms of both earnings multiples and total market value, reflecting differences in their respective business mixes and earnings bases.
The company is scheduled to report its third-quarter 2026 financial results on October 20, 2026. Market consensus expectations for the upcoming quarter project earnings per share of USD 7.16 and revenue of USD 11.14 billion. Analysts note that the current valuation comparison with peers is descriptive rather than a definitive verdict on the company's intrinsic value.
Northrop Grumman operates as a defense-focused business serving aerospace and military customers, primarily listed on the NYSE. While specific stock price movements for the day were not detailed in the primary text, the article provides real-time context regarding trading spreads and quotes from European exchanges like Lang & Schwarz alongside US market data.
π NOC trades at 15.23x earnings multiple with USD 68.3B market cap.
π Valuation is lower than peers Lockheed Martin and RTX due to business mix.
π Q3 2026 results scheduled for October 20, 2026.
π° Analysts expect USD 7.16 EPS and USD 11.14B revenue for the quarter.
πΆ NOC quoted at EUR 429.50 on European exchanges.
π Northrop Grumman trades at a 15.23 earnings multiple with a market cap of USD 68.3 billion as of October 13, 2026.
π The company's valuation is lower than peers Lockheed Martin (18.61x) and RTX (32.13x), reflecting different business mixes.
π Northrop Grumman is scheduled to report third-quarter 2026 results on October 20, 2026.
π° Analyst consensus expects USD 7.16 in earnings per share and USD 11.14 billion in revenue for the upcoming quarter.
π’ The company operates as a defense-focused business serving aerospace and military customers.
πΆ Real-time trading data shows Northrop Grumman quoted at EUR 429.50 on European exchanges.
Bullish Signals
Market cap is USD 68.3 billion.
Q3 earnings due October 20, 2026.
Risk Factors
P/E multiple of 15.23 is lower than peers.
Market cap of USD 68.3B is smaller than competitors.
Bullish Signals
Northrop Grumman maintains a solid market capitalization of USD 68.3 billion, indicating significant scale in the defense sector.
The company has clear upcoming earnings visibility with third-quarter results scheduled for October 20, 2026.
Risk Factors
Northrop Grumman trades at a lower price-to-earnings multiple of 15.23 compared to peers Lockheed Martin and RTX.
The company's market capitalization of USD 68.3 billion is significantly smaller than that of competitors Lockheed Martin (USD 116.5 billion) and RTX (USD 245.8 billion).
Northrop Grumman (NOC) reported second-quarter revenue of USD 10.88 billion, representing a 5.10% year-over-year increase, with adjusted earnings per share reaching USD 7.68. The company maintains a substantial order backlog of USD 105.00 billion, which rose 17% year over year, providing a robust foundation for future revenue despite current market fluctuations.
Analyst firm TD Cowen recently lowered its price target for Northrop Grumman from USD 590.00 to USD 540.00 while retaining a Hold rating on October 9, 2026. This adjustment reflects concerns regarding program cost pressures specifically within the Defense Systems and Space sectors, including unfavorable adjustments tied to the Stand-in Attack Weapon program.
Despite the analyst downgrade, management maintained adjusted free cash flow guidance between USD 3.10 billion and USD 3.50 billion for fiscal year 2026. The company is scheduled to report third-quarter results on October 20, 2026, with investors closely watching whether the recent pattern of revenue growth persists alongside ongoing execution risks related to specific defense programs.
Northrop Grumman's market capitalization stands at approximately USD 68.3 billion as of early October 2026. The stock trades in a complex environment where strong backlog numbers coexist with specific cost challenges, leading analysts to temper their price targets while acknowledging the long-term demand narrative remains intact.
π Q2 revenue rose 5.1% to USD 10.88 billion.
π° Adjusted EPS reached USD 7.68 for the quarter.
π¦ Order backlog grew 17% to USD 105.00 billion.
β οΈ Defense Systems took a USD 68M unfavorable adjustment.
π Space division faces cost pressure on GEM 63XL program.
π Northrop Grumman reported Q2 revenue of USD 10.88 billion, up 5.10% year over year.
π° The company achieved adjusted earnings per share of USD 7.68 for the second quarter.
π¦ Order backlog increased to USD 105.00 billion, a 17% rise year over year.
π TD Cowen cut its price target from USD 590.00 to USD 540.00 on October 9, 2026.
βοΈ Analysts retained a Hold rating despite the reduction in the price target.
β οΈ Defense Systems recorded a USD 68.00 million unfavorable adjustment for the Stand-in Attack Weapon program.
π Space division cited cost pressure on the GEM 63XL program during the earnings call.
π΅ Management maintained free cash flow guidance of USD 3.10 billion to USD 3.50 billion for FY2026.
π The company is scheduled to report Q3 results on October 20, 2026.
π’ Northrop Grumman operates in the Industrials sector with a focus on Aerospace and Defense.
π° Market capitalization was approximately USD 68.3 billion as of October 9, 2026.
Bullish Signals
Revenue grew 5.10% YoY to USD 10.88 billion.
Order backlog expanded 17% to USD 105.00 billion.
Maintained adjusted free cash flow guidance of USD 3.10-3.50 billion.
Risk Factors
TD Cowen lowered price target from $590 to $540 due to costs.
Defense Systems took $68M unfavorable adjustment for Stand-in Attack Weapon.
Space division faces cost pressure on GEM 63XL program.
Bullish Signals
Northrop Grumman achieved second-quarter revenue growth of 5.10% year over year, reaching USD 10.88 billion.
The company's order backlog expanded to USD 105.00 billion, up 17% year over year, indicating strong future demand.
Management maintained adjusted free cash flow guidance of USD 3.10 billion to USD 3.50 billion for fiscal year 2026 despite cost pressures.
Risk Factors
TD Cowen lowered its price target from USD 590.00 to USD 540.00, citing program cost pressures.
Defense Systems incurred a USD 68.00 million unfavorable adjustment related to the Stand-in Attack Weapon program.
The Space division reported specific cost pressure on the GEM 63XL program during the earnings call.
Northrop Grumman Corporation (NYSE: NOC) is highlighted as a top space stock with a consensus Buy rating and an average share price upside potential of 15.43% as of January 16, 2025. Analysts cite strong financial performance in the third quarter of fiscal 2024, where the company reported $10 billion in sales, up 2% year-over-year, driven by increased demand for advanced weapons systems amid global conflicts.
The defense contractor secured a significant contract extension in December 2024 for Phase 2 of its Next Gen OPIR Polar (NGP) program for the U.S. Space Force. This multi-year award advances the development of ground systems and space vehicles designed to detect missile threats from the North Pole using advanced sensors, reinforcing NOC's strategic position in national security.
Despite a slight 3% decline in Space Systems sales due to the wind-down of specific programs like NGI, the segment saw a $129 million increase in Space Development Agency satellite programs. Overall, operating income rose 14% with an operating margin of 12%, reflecting robust profitability. The company is also the manufacturer of the B-21 Raider stealth bomber, further diversifying its high-value defense portfolio.
While NOC ranks 10th on a list of best space stocks, analysts note that broader sentiment supports the sector due to national security needs and major initiatives like the Artemis program. However, the article suggests AI stocks may offer higher returns in shorter timeframes, positioning NOC as a solid but not exclusive play within the aerospace and defense complex.
π Consensus Buy rating with 15.43% upside potential as of Jan 16, 2025.
π° Q3 sales hit $10 billion, up 2% driven by Middle East and Ukraine demand.
π Secured Phase 2 contract extension for Next Gen OPIR Polar missile detection program.
πΉ Operating income rose 14% with $1 billion net earnings, beating EPS estimates.
π Northrop Grumman (NOC) holds a consensus Buy rating with an average share price upside potential of 15.43% as of January 16, 2025.
π° Q3 fiscal 2024 sales reached $10 billion, up 2% year-over-year, driven by demand for advanced weapons in the Middle East and Ukraine-Russia conflicts.
π The company secured a contract extension in December 2024 for Phase 2 of its Next Gen OPIR Polar (NGP) program to detect missile threats from the North Pole.
π‘οΈ NOC is the manufacturer of the B-21 Raider, a long-range stealth strategic bomber intended to replace aging fleets.
π Space Systems sales dropped 3% due to the wind-down of NGI and space programs, impacting sales by $224 million.
π°οΈ The Space Development Agency (SDA) satellite programs contributed a $129 million increase in Space Systems segment revenue.
πΉ Operating income increased 14% year-over-year with an operating margin rate of 12% in the third quarter.
π Analysts attribute sector strength to national security demands, the Artemis program, and the Trump-Elon trade following the 2024 election.
π Net earnings totaled $1 billion, translating to a diluted EPS of $7, beating analyst estimates of $6.08 per share.
Bullish Signals
Q3 sales hit $10B, up 2% YoY on weapons demand.
Risk Factors
Space Systems sales declined $83M due to program wind-downs.
Space Systems sales fell $224M from specific program cuts.
Bullish Signals
Northrop Grumman achieved Q3 fiscal 2024 sales of $10 billion, representing a 2% year-over-year increase driven by demand for advanced weapons systems.
The company reported net earnings of $1 billion with diluted EPS of $7, surpassing analyst estimates of $6.08 per share.
Operating income rose 14% from the previous year while maintaining a healthy operating margin rate of 12%.
Northrop Grumman was awarded a contract extension in December 2024 for Phase 2 of its Next Gen OPIR Polar (NGP) program, moving into manufacturing and assembly.
The Space Development Agency (SDA) satellite programs drove a $129 million increase in revenue within the Space Systems segment.
Analysts assign NOC a consensus Buy rating with an average share price upside potential of 15.43% as of mid-January 2025.
Risk Factors
Space Systems sales declined by $83 million, or 3%, during the third quarter due to the wind-down of work on the NGI and space programs.
The wind-down of specific space programs negatively impacted total Space Systems sales by $224 million in Q3 fiscal 2024.
Northrop Grumman (NOC) secured a $508.5 million Missile Defense Agency contract on September 4, 2026, for ICBM and IRBM target flight-test support extending through 2035. This non-competitive award follows approximately $3 billion in framework agreements to expand solid-rocket-motor production for PAC-3 and THAAD interceptors, alongside $1.4 billion in IBCS-related awards announced previously. Despite these significant bookings, the stock slipped 2.5% to $515, trading near 16 times earnings and roughly 33% below its peak.
The company remains one of the largest-cap defense contractors with exposure to the Golden Dome program via space sensors and interceptors, as well as the Sentinel ICBM and B-21 bomber programs. However, the stock trades at a discount compared to peers like Lockheed Martin due to execution problems in major developmental programs. Specifically, the Sentinel ICBM program triggered a critical Nunn-McCurdy breach after projected costs rose 81% to roughly $141 billion, forcing Pentagon restructuring.
Concurrently, low-rate initial production on the B-21 bomber generated approximately $2 billion in pre-tax charges on fixed-price commitments. Management must demonstrate that these losses have ceased before multiple expansion can resume. While institutional positioning shows 59 hedge funds holding NOC in Q2 2026 and short interest remains low at 1.7%, the primary valuation driver is margin pressure and cost discipline on these major programs rather than contract volume alone.
πΈ B-21 production generated ~$2B pre-tax charges on fixed-price commitments.
π‘οΈ New MDA contract includes cost-plus elements to reduce financial exposure.
π Institutional holdings dropped from 62 to 59 hedge funds in Q2 2026.
π Northrop Grumman stock slipped 2.5% to $515 despite securing a $508.5 million MDA contract and ~$3 billion in framework agreements for solid-rocket-motor production.
π The company holds significant exposure to the Golden Dome program through space sensors, interceptors, and the Sentinel ICBM system.
β οΈ The Sentinel ICBM program triggered a critical Nunn-McCurdy breach after projected costs surged 81% to roughly $141 billion, necessitating Pentagon restructuring.
πΈ Low-rate initial production on the B-21 bomber generated approximately $2 billion in pre-tax charges on fixed-price commitments.
π Northrop Grumman trades at about 16 times earnings, significantly lower than Lockheed Martin's 19x multiple and 33% below its peak price.
π‘οΈ The latest MDA contract includes cost-plus and cost-reimbursable elements to reduce financial exposure compared to purely fixed-price development work.
π Institutional holdings decreased slightly from 62 hedge funds in Q1 2026 to 59 in Q2 2026, though short interest remains low at 1.7%.
π Management must demonstrate that losses from Sentinel and B-21 programs have ceased before the stock's multiple can expand significantly.
Bullish Signals
Secured $508.5M MDA contract for flight-test support through 2035.
Risk Factors
Sentinel ICBM costs rose 81% to $141B, triggering Nunn-McCurdy breach.
Bullish Signals
Northrop Grumman secured a $508.5 million Missile Defense Agency contract for ICBM and IRBM target flight-test support running through 2035.
The company has approximately $3 billion in framework agreements to expand solid-rocket-motor production for PAC-3 and THAAD interceptors.
Northrop Grumman received an additional $1.4 billion in IBCS-related U.S. and Polish air-and-missile-defense awards announced in 2025.
The latest MDA contract includes cost-plus, cost-reimbursable, and fixed-price-incentive elements which reduce some financial exposure compared with purely fixed-price development work.
Northrop Grumman offers portfolio diversification with a -0.11 beta and a 1.9% dividend yield.
Risk Factors
The Sentinel ICBM program triggered a critical Nunn-McCurdy breach after projected costs rose 81% to roughly $141 billion, forcing a Pentagon program restructuring.
Low-rate initial production on the B-21 bomber generated approximately $2 billion in pre-tax charges on fixed-price commitments.
Long-term missile-shield funding remains tied to both political and defense bets, introducing timing risk via legislative approval.
Further charges such as those incurred on Sentinel or the B-21 will keep the multiple depressed until losses cease.
Northrop Grumman (NOC) shares rose on September 8, 2026, following a price target increase by UBS and the announcement of a significant new contract. The defense contractor secured an $862.8 million firm-fixed-price, indefinite-delivery/indefinite-quantity agreement from the U.S. Army to manufacture M1156 Precision Guidance Kits and variants. This award adds substantial multi-year revenue to the company's ammunition and precision guidance segment, representing approximately 2.0% of its historical fiscal year 2025 revenue base.
The positive market reaction is underpinned by robust recent earnings performance that has consistently exceeded analyst expectations. In the quarter ended June 30, 2026, Northrop Grumman reported revenue of $10.88 billion and earnings of $1.09 billion, achieving a profit margin of 10.06%. The company delivered an EPS of $7.68 against a consensus estimate of $6.82, resulting in a positive surprise of $0.86 per share or 12.66% for the period.
Analyst consensus data indicates continued growth expectations for Northrop Grumman, with average full-year 2026 EPS estimates reaching $28.99 and projected to rise to $30.44 in 2027. UBS has raised its price target to $704 while maintaining a Buy rating, implying significant upside potential relative to the stock's trading levels around $517. Investors view these metrics as consistent with a high-quality defense contractor delivering double-digit margins and steady cash flows.
β οΈ UBS raised NGC price target to $704, maintaining Buy rating.
π° Secured $862.8M Army contract for M1156 Precision Guidance Kits.
π Q2 2026 earnings hit $1.09B with 10.06% profit margin.
π Analysts project full-year 2026 EPS growth of roughly 10.1%.
βοΈ Competing with Boeing for Pentagon's next-gen F/A-XX stealth fighter.
π UBS raised its price target for Northrop Grumman to $704 on September 8, 2026, maintaining a Buy rating as shares trade around $517.
π° The company secured an $862.8 million firm-fixed-price contract from the U.S. Army for M1156 Precision Guidance Kits and variants.
π Northrop Grumman reported Q2 2026 earnings of $1.09 billion with a profit margin of 10.06%, beating EPS estimates by 12.66%.
π Analyst consensus projects full-year 2026 EPS growth of roughly 10.1% compared to the prior fiscal year, reaching $28.99.
βοΈ The company is a leading contender for the Pentagon's next-generation F/A-XX stealth fighter contract alongside Boeing.
π‘οΈ Northrop Grumman is advancing its Integrated Battle Command System (IBCS) to integrate data from multiple sensors into a unified fire control network.
Risk Factors
Faces competition for Navy F/A-XX stealth fighter contract from Boeing.
Bullish Signals
UBS raised its price target for Northrop Grumman to $704 on September 8, 2026, maintaining a Buy rating and signaling further appreciation potential.
The company secured an $862.8 million firm-fixed-price contract from the U.S. Army for M1156 Precision Guidance Kits, adding a sizable multi-year revenue stream.
Northrop Grumman delivered Q2 2026 earnings of $1.09 billion with a profit margin of 10.06%, significantly beating EPS estimates by $0.86 per share.
Analyst consensus expects full-year 2026 EPS to reach $28.99, representing approximately 10.1% growth compared to the prior fiscal year.
The company is a leading contender for the Pentagon's next-generation F/A-XX stealth fighter contract, which could drive future revenue in its advanced air systems segment.
Risk Factors
Northrop Grumman faces competitive risks regarding the Pentagon's decision on the Navy's next-generation F/A-XX stealth fighter contract against rivals like Boeing.
Northrop Grumman (NOC) reported strong quarterly financial results, exceeding analyst expectations with earnings per share of $7.68 against a consensus of $6.82 and revenue of $10.88 billion versus an estimate of $10.80 billion. The company demonstrated robust profitability with a net margin of 10.48% and a return on equity of 24.25%, while posting year-over-year revenue growth of 5.1%. Management provided fiscal 2026 EPS guidance ranging from $28.60 to $29.10, which aligns closely with the average analyst prediction of $28.97 for the current fiscal year.
Institutional ownership remains high at 83.4%, highlighted by a significant 460% increase in stake from Caisse de depot et placement du Quebec, which acquired over 60,000 shares worth approximately $37.7 million in the second quarter. Other major institutional investors, including BlackRock, Capital World Investors, and Geode Capital Management, also increased their holdings during the fourth quarter, signaling continued confidence in the company's strategic position within the aerospace and defense sector.
Analysts maintain a generally positive outlook on Northrop Grumman, with a consensus rating of 'Moderate Buy' and an average price target of $661.30, though individual targets vary between $590 and $667. Recent analyst actions include Citigroup raising its price target to $667 with a 'buy' rating and Wells Fargo reaffirming an 'overweight' rating at $620, while JPMorgan Chase lowered its target to $600 with a neutral rating. The company also declared a quarterly dividend of $2.47 per share, implying an annual yield of 1.8%.
π NOC beat earnings with EPS of $7.68 and revenue of $10.88B.
π Fiscal 2026 EPS guidance set between $28.60 and $29.10.
π¦ Quebec Caisse increased stake by 460% to acquire 60,861 shares.
π° Quarterly dividend declared at $2.47 per share with 1.8% yield.
π Stock trades below 200-day moving average of $604.78.
π Northrop Grumman beat quarterly earnings expectations with EPS of $7.68 and revenue of $10.88 billion.
π The company issued fiscal 2026 EPS guidance between $28.60 and $29.10, aligning with analyst consensus.
π¦ Caisse de depot et placement du Quebec increased its stake by 460% to acquire 60,861 shares worth $37.7 million.
π Institutional investors collectively own 83.4% of the company's outstanding stock.
π° Northrop Grumman declared a quarterly dividend of $2.47 per share with an annualized yield of 1.8%.
π Analyst consensus rating is 'Moderate Buy' with an average price target of $661.30.
π Citigroup raised its price target to $667 and reaffirmed a 'buy' rating on the stock.
π JPMorgan Chase lowered its price target to $600 and assigned a neutral rating.
π Northrop Grumman stock is trading below its 200-day simple moving average of $604.78.
π’ The company has a market capitalization of $77.52 billion and a PE ratio of 17.34.
Bullish Signals
Northrop Grumman exceeded quarterly earnings expectations, reporting EPS of $7.68 versus the consensus estimate of $6.82.
The company reported revenue of $10.88 billion, surpassing analyst estimates of $10.80 billion and achieving 5.1% year-over-year growth.
Caisse de depot et placement du Quebec significantly increased its position by 460%, acquiring 60,861 shares valued at approximately $37.7 million.
Major institutional investors including BlackRock and Capital World Investors increased their stakes in the second or fourth quarter.
Analysts maintain a consensus 'Moderate Buy' rating with an average price target of $661.30, indicating confidence in future performance.
Citigroup raised its price target to $667 and assigned a 'buy' rating, while Wells Fargo reaffirmed an 'overweight' rating at $620.
Risk Factors
JPMorgan Chase lowered its price target from $635.00 to $600.00 and downgraded the stock to a neutral rating.
TD Cowen reduced its price objective from $550.00 to $590.00 and assigned a 'hold' rating in a recent research report.
Northrop Grumman's stock price is currently trading below its 200-day simple moving average of $604.78.
Ascentis Independent Advisors significantly increased its position in Northrop Grumman (NYSE: NOC) by 142.8% in the first quarter, purchasing an additional 1,909 shares to hold a total of 3,246 shares valued at $2.215 million according to recent SEC filings.
Several other institutional investors have also adjusted their stakes in the aerospace and defense giant during the fourth quarter, with Torren Management LLC, Karpus Management Inc., Financial Life Planners, Kohmann Bosshard Financial Services LLC, and Motiv8 Investments LLC all establishing new positions valued between $26,000 and $30,000.
Northrop Grumman recently declared a quarterly dividend of $2.47 per share paid on June 17th to stockholders of record as of June 1st, representing an increase from the previous quarter's payout and resulting in an annualized dividend yield of 1.8% with a payout ratio of 30.92%.
Analyst sentiment remains mixed regarding the company's valuation targets, with BTIG Research raising its price target to $815.00 and Wells Fargo initiating coverage with an overweight rating, while UBS Group and Morgan Stanley lowered their respective price objectives to $745.00 amidst a broader average target of $698.37.
π Ascentis Advisors increased Northrop Grumman holdings by 142.8% to 3,246 shares.
π° Five new institutional investors added stakes valued between $26,000 and $30,000.
π Institutional ownership of Northrop Grumman reached 83.40% in the latest period.
π΅ Quarterly dividend of $2.47 raised annualized yield to 1.8% with 30.92% payout.
π― Analyst consensus target price is $698.37 with a Moderate Buy rating.
π Ascentis Independent Advisors boosted its Northrop Grumman holdings by 142.8% in Q1, adding 1,909 shares to a total position of 3,246 shares.
π° Five other institutional investors established new stakes in NOC during the fourth quarter with values ranging from $26,000 to $30,000.
π Institutional ownership of Northrop Grumman stands at 83.40% as of the latest reporting period.
π΅ The company declared a quarterly dividend of $2.47 per share, increasing the annualized yield to 1.8% and maintaining a healthy 30.92% payout ratio.
π Shares of NOC opened at $547.06, trading below its 200-day moving average of $626.92 but above its 50-day moving average of $544.85.
π― BTIG Research restated a buy rating with an increased price target of $815.00 for Northrop Grumman shares.
π UBS Group and Morgan Stanley both lowered their price objectives to $745.00 while maintaining buy or overweight ratings.
ποΈ Wells Fargo initiated coverage on the stock with an overweight rating and a $800.00 price target.
βοΈ Weiss Ratings downgraded Northrop Grumman from a buy to a hold rating, reflecting divergent analyst opinions.
π MarketBeat data indicates an average analyst rating of Moderate Buy with a consensus target price of $698.37.
Bullish Signals
Ascentis increased position 142.8% Q1.
Five new institutional investors added positions.
Quarterly dividend raised to $2.47.
BTIG upgraded with $815 price target.
Wells Fargo initiated overweight rating.
Risk Factors
UBS and Morgan Stanley lowered price targets to $745.
Weiss Ratings downgraded stock from buy to hold.
Stock trades below 200-day moving average of $626.92.
Bullish Signals
Ascentis Independent Advisors increased its position by 142.8% in Q1, signaling strong institutional confidence in the company's long-term prospects.
Five separate institutional investors established new positions in Northrop Grumman during the fourth quarter, indicating growing interest from smaller funds.
The company raised its quarterly dividend to $2.47 per share, demonstrating a commitment to returning capital to shareholders and supporting the stock price.
BTIG Research upgraded its outlook with a buy rating and a high price target of $815.00, suggesting potential upside from current levels.
Wells Fargo initiated coverage with an overweight rating, validating the company's strategic position in the aerospace and defense sector.
Risk Factors
UBS Group reduced its price objective to $745.00, indicating some analysts see limited near-term upside from current trading levels.
Morgan Stanley lowered its price target to $745.00, reflecting a more conservative valuation compared to previous estimates.
Weiss Ratings downgraded the stock from a buy to a hold rating, highlighting concerns about the company's immediate growth trajectory or valuation.
The stock is trading below its 200-day moving average of $626.92, which may indicate short-term weakness or lack of momentum compared to longer-term trends.
Northrop Grumman (NOC) shares are trading near their 52-week low of $487.68, closing at $499.58 on June 25, 2026, with a market capitalization of approximately $71 billion. The stock is currently hovering around the $500 mark on the NYSE, prompting analysts to reassess targets and ratings within the broader U.S. defense sector.
Analyst sentiment remains mixed regarding valuation but generally constructive for the company's long-term prospects. The average price target stands at $702 per share, suggesting significant theoretical upside from current levels if medium-term growth plans are executed successfully. However, recent adjustments by major firms like Jefferies and Citi reflect a nuanced view of immediate headwinds.
Specific analyst actions highlight concerns over organic growth and margin pressure associated with the ramp-up of the B-21 Raider stealth bomber program. While Jefferies lowered its target to $620 with a Hold rating, Citi maintained a Buy rating at $628, arguing that sector-wide sentiment is currently constrained by geopolitical uncertainties rather than company-specific issues.
π Shares closed at $499.58 near 52-week low of $487.68.
π° Market cap stands at approximately $71 billion.
π― Analyst average price target is $702 per share.
β οΈ Margins face pressure from B-21 Raider program ramp-up.
π‘οΈ Geopolitical uncertainty and defense contracts drive sector drag.
π Northrop Grumman shares closed at $499.58 on June 25, 2026, trading just above the 52-week low of $487.68.
π° The company holds a market capitalization of approximately $71 billion as reported by TradingKey.
π― Analyst consensus shows an average price target of $702 per share, indicating potential upside from current trading levels.
π Jefferies lowered its price target to $620 and maintained a Hold rating due to below-average organic growth.
β οΈ Margins are facing dilution pressure specifically linked to the ramp-up of the B-21 Raider bomber program.
π‘οΈ Citi trimmed its target to $628 but kept a Buy rating, citing geopolitical uncertainty as the primary sector drag.
π Northrop Grumman is a key contractor for U.S. national security, supplying missile defense and space systems.
βοΈ The company generates most of its revenue through aerospace and defense systems including advanced surveillance platforms.
$702 price target implies substantial upside from sub-$500 band.
Citi Buy rating suggests weakness is macro-driven, not company-specific.
Risk Factors
Jefferies lowered target to $620 due to growth and margin issues.
Stock trades near 52-week low amid market skepticism.
Geopolitical uncertainty caps sector sentiment and limits short-term gains.
Bullish Signals
Analysts broadly maintain a constructive view on Northrop Grumman despite short-term valuation concerns.
The average analyst price target of $702 implies substantial theoretical upside from the current sub-$500 trading band.
Citi maintains a Buy rating, suggesting that current market weakness is driven by macro geopolitical factors rather than company-specific deterioration.
Risk Factors
Jefferies lowered its price target to $620 citing below-average organic growth and margin dilution from the B-21 bomber ramp-up.
The stock is trading near its 52-week low, reflecting current market skepticism or lack of immediate catalysts.
Sector sentiment is currently capped by broader geopolitical uncertainties, which may limit short-term stock performance regardless of company fundamentals.
Northrop Grumman (NOC) shares are under renewed analyst scrutiny as major Wall Street firms adjust price targets amidst a debate over valuation versus robust defense spending. While the company maintains strong operating margins and exposure to high-priority U.S. and allied programs, analysts like those at Jefferies and Raymond James are revising targets downward or holding steady, citing that current share prices already discount significant growth potential from strategic deterrence and advanced aircraft projects.
Jefferies specifically lowered its price target on Northrop Grumman from $660 to $620 while maintaining a 'Buy' rating. The firm acknowledges the durability of demand tied to long-cycle defense programs but argues that valuation metrics, such as forward earnings multiples, are now demanding. This adjustment reflects a view that the stock trades near the upper end of its historical range on price-to-earnings and enterprise-value-to-EBITDA, requiring new fundamental catalysts like major contract awards or structural margin improvements to justify further upside.
The company has demonstrated consistent financial strength, posting operating margins above 12% in seven of eight recent quarters and recently beating adjusted earnings per share expectations by approximately 17%. However, analysts are questioning the sustainability of repeated earnings surprises once they are fully reflected in forward estimates. The core narrative remains that Northrop Grumman is a high-quality defense holding with stable margins, but tactical entry points matter as multiples approach historical highs without new growth drivers.
Broader market context includes sustained U.S. Pentagon spending and structural demand for advanced aircraft, missile defense systems, and space systems driven by geopolitical tensions. While institutional investors may adjust positions gradually, the cumulative effect of analyst revisions suggests a focus on valuation discipline rather than a fundamental deterioration in business quality. Future stock performance will likely depend on whether the company can deliver results that match ambitious expectations built around its major defense pipelines.
π° Operating margins exceeded 12% across seven recent quarters.
π Adjusted revenue reached $22.1 billion with strong EPS.
π‘οΈ Demand driven by U.S. budgets and geopolitical tensions.
β οΈ Risks include schedule delays and shifting customer priorities.
π Jefferies lowered its Northrop Grumman price target from $660 to $620 while maintaining a 'Buy' rating due to elevated valuation metrics.
π’ Raymond James revised its price target citing valuation concerns despite recognizing the company's strong position in high-priority defense programs.
π° Northrop Grumman posted operating margins above 12% in seven of eight recent quarters, demonstrating disciplined cost control and a favorable program mix.
π The company recently generated adjusted revenue of approximately $22.1 billion with EPS exceeding analyst expectations by roughly 17%.
π‘οΈ Demand remains structurally supported by U.S. defense budgets, NATO allies, and geopolitical tensions requiring advanced aircraft and missile defense systems.
π Analysts note that Northrop Grumman trades near the upper end of its historical range on P/E and EV/EBITDA multiples without new catalysts.
β οΈ Risks include potential schedule changes, cost reviews, or shifts in customer priorities on large, complex defense programs.
π Institutional investors are expected to adjust position sizes gradually rather than making abrupt moves following these target revisions.
π Key future catalysts include additional large contract awards, structural margin improvements, or higher-than-expected guidance updates.
ποΈ The company operates out of Falls Church, Virginia, with core markets in U.S. and allied defense, aerospace, space systems, and intelligence.
Bullish Signals
Operating margins above 12% in seven of eight recent quarters.
Beat adjusted EPS expectations by approximately 17% recently.
Demand underpinned by robust U.S. defense budgets and NATO priorities.
Jefferies maintains a 'Buy' rating despite lowering price target.
Part of major U.S. defense benchmarks for sector reassessments.
Risk Factors
Prices already discount significant growth from major defense programs.
Forward earnings multiples viewed as demanding by Jefferies.
Analysts question how much incremental surprise can be sustained.
High P/E and EV/EBITDA raise bar for target hikes.
Bullish Signals
Northrop Grumman has sustained operating margins above 12% in seven of eight recent quarters, indicating strong cost discipline.
The company recently beat adjusted earnings per share expectations by approximately 17%, demonstrating consistent outperformance.
Demand for Northrop Grumman's products is structurally underpinned by robust U.S. defense budgets and modernization priorities among NATO allies.
Jefferies maintains a 'Buy' rating despite lowering the price target, signaling confidence in the company's long-term fundamentals.
The stock is part of major U.S. defense benchmarks, making it a key reference point for sector-wide reassessments.
Northrop Grumman holds a strategic footprint in critical areas like space systems, intelligence, surveillance, and reconnaissance.
Risk Factors
Analysts are concerned that current share prices already discount a significant amount of the company's growth prospects from major defense programs.
Jefferies lowered its price target due to valuation metrics such as forward earnings multiples being viewed as demanding.
Repeated earnings beats may lead analysts to question how much incremental surprise can be realistically sustained into future years.
Northrop Grumman trades closer to the upper end of its historical range on P/E and EV/EBITDA, raising the bar for further target hikes without new catalysts.
Northrop Grumman Corp. is expanding its manufacturing capabilities with a new $20 million, 130,000-square-foot facility in Hanover, Maryland, which will increase production of spacecraft components. Air Products announced a $70 million renovation of its Missouri Manufacturing and Logistics Center in Maryland Heights to meet growing demand for hydrogen recovery, biogas, and nitrogen applications in aerospace and other industries. Additionally, Air Liquide is investing in French startup Quobly through its venture capital arm ALIAD to support the scaling of silicon-based quantum processing technology. ATC Co. agreed to acquire Aero Controls, Inc., combining their aerospace component maintenance and repair services to expand market reach in the Pacific Northwest. Finally, Mobix Labs plans to acquire Vision Aerial Inc. to enter the drone and aerial intelligence markets, though specific deal terms were not disclosed.
π Companies invested $90M+ in new factories and facility renovations across the US and France.
π Industrial firms are expanding capacity to maintain competitiveness despite adverse market conditions.
π Northrop Grumman opened a new $20 million, 130,000-square-foot factory in Hanover, Maryland to boost spacecraft component production.
π§ͺ Air Products completed a $70 million renovation of its Missouri Manufacturing and Logistics Center to meet rising demand for hydrogen recovery and nitrogen gas.
π Air Liquide invested in French startup Quobly through its venture capital arm ALIAD to advance silicon-based quantum computing technology.
βοΈ ATC Co. agreed to acquire Aero Controls, Inc. to combine aerospace maintenance services and expand its Pacific Northwest market presence.
πΈ Mobix Labs plans to acquire Vision Aerial Inc. to enter the drone manufacturing and aerial intelligence markets.
π All five major business deals were announced between June 3 and June 4 by industrial companies seeking competitive expansion.
π€ These strategic moves include both physical facility expansions and acquisitions of specialized technology or service businesses.
π¬ The investments highlight growing industry interest in advanced fields such as quantum computing, hydrogen recovery, and drone intelligence.
π Industrial firms are actively merging and investing to maintain competitiveness despite adverse business conditions.
π The new facilities and partnerships aim to increase production capacity and deepen expertise in complex aircraft components.
Bullish Signals
Northrop Grumman builds $20M factory for spacecraft components.
Air Products renovates Missouri center for hydrogen recovery.
Air Liquide invests in Quobly for quantum processing.
ATC Co. acquires Aero Controls for aircraft expertise.
Mobix Labs acquires Vision Aerial for drone market.
Risk Factors
$70M renovation shows substantial ongoing capital investment needs.
Bullish Signals
Northrop Grumman Corp. is expanding its production capabilities with a new $20 million, 130,000-square-foot factory in Hanover, Maryland, dedicated to manufacturing spacecraft components.
Air Products announced a $70 million renovation of its Missouri Manufacturing and Logistics Center to meet increasing demand for hydrogen recovery, biogas, and nitrogen applications in aerospace.
Air Liquide is investing in French startup Quobly via its venture capital arm ALIAD to scale silicon-based quantum processing, positioning itself at the next major technological frontier.
ATC Co. agreed to acquire Aero Controls, Inc., which will add deep expertise in complex aircraft components and expand its market reach in the Pacific Northwest.
Mobix Labs, Inc. plans to acquire Vision Aerial Inc. to enter the drone and aerial intelligence markets, diversifying its portfolio beyond fabless semiconductor development.
Risk Factors
Air Products announced a $70 million renovation of its manufacturing center, indicating substantial ongoing capital investment requirements to meet growing demand.
Northrop Grumman has announced a partnership with satellite manufacturer Apex to develop and demonstrate space-based missile interceptors as part of the U.S. government's Golden Dome initiative. The collaboration aims to expand homeland missile defense capabilities by utilizing Apex's expertise in building standardized satellite buses for interceptor constellations. This strategic move supports Northrop Grumman's broader efforts to integrate advanced technologies into its defense portfolio, with a target demonstration scheduled for 2027. While the project faces potential technical, budgetary, and policy hurdles before becoming fully operational, the partnership highlights significant long-term opportunities within the defense and space sectors if these interceptors are successfully fielded.
π Northrop Grumman selected Apex for space-based missile interceptor development.
π°οΈ Project targets a 2027 demonstration under the Golden Dome program.
β οΈ Analysts warn of significant technical, budgetary, and policy hurdles ahead.
π Northrop Grumman has selected Apex to support the development and demonstration of space-based missile interceptors.
π‘οΈ This partnership is part of a U.S. government initiative aimed at expanding homeland missile defense capabilities.
π°οΈ The project focuses on the Golden Dome program, which targets a demonstration by 2027.
π€ Apex will provide satellite capabilities and standardized satellite buses for interceptor constellations.
π Northrop Grumman is leveraging its expertise to integrate these technologies into space-based defensive systems.
β οΈ Analysts note that significant technical, budgetary, and policy hurdles remain before the network becomes operational.
πΌ The collaboration could offer long-term investment opportunities for defense and space sector companies if fielded successfully.
π The announcement was made on Monday, June 1, 2026.
π’ Northrop Grumman trades under the ticker symbol NOC on the NYSE.
π The initiative aims to demonstrate new technologies for intercepting threats from space.
Bullish Signals
Northrop Grumman partners with Apex on Golden Dome missile interceptors.
Apex provides satellite buses for efficient interceptor constellation building.
Success unlocks long-term growth for Northrop Grumman and defense sector.
Risk Factors
Golden Dome faces technical, budget, and policy hurdles delaying interceptor network.
Space-based defense risks deployment delays and regulatory obstacles.
Apex partnership is demo; commercial revenue unlikely until years later.
Bullish Signals
Northrop Grumman has secured a strategic partnership with Apex to develop and demonstrate space-based missile interceptors for the U.S. government's Golden Dome initiative.
Apex will provide critical satellite capabilities and standardized satellite buses, enabling Northrop Grumman to build interceptor constellations efficiently.
The collaboration targets a demonstration in 2027, positioning Northrop Grumman at the forefront of next-generation homeland missile defense technologies.
If successfully fielded, this project could unlock significant long-term growth opportunities for Northrop Grumman and the broader defense sector.
Risk Factors
The Golden Dome project faces significant technical, budgetary, and policy hurdles before the interceptor network becomes operational.
Space-based missile defense initiatives carry inherent risks related to deployment timelines and potential regulatory or political obstacles that could delay fielding.
The partnership with Apex is a demonstration effort, meaning commercial revenue from this specific initiative may not materialize until successful fielding occurs years later.
Northrop Grumman Corporation (NYSE: NOC) announced a quarterly cash dividend of $2.47 per share on its common stock. The board declared this payout as part of the company's disciplined capital allocation strategy, which balances returning value to shareholders with significant investments in manufacturing capabilities and capacity.
The dividend is scheduled to be payable on June 17, 2026, to shareholders of record as of the close of business on June 1, 2026. This announcement aligns with the company's broader mission to equip customers with advanced aerospace and defense technologies while pushing the boundaries of human exploration.
Market reaction on the day of publication showed a mild decline of 0.98% for NOC stock. The article emphasizes that this dividend declaration is consistent with the firm's ongoing approach to funding operations and delivering differentiating technologies quickly for its global customer base.
π $2.47 quarterly cash dividend declared for common stock.
π° Payment date set for June 17, 2026.
π Record date is close of business June 1, 2026.
π Payout supports manufacturing capabilities and capacity investments.
π Focus remains on differentiating aerospace and defense technologies.
π Northrop Grumman declared a quarterly cash dividend of $2.47 per share on common stock.
π° The dividend payment date is set for June 17, 2026.
π The record date for eligibility is the close of business on June 1, 2026.
π The payout supports a strategy prioritizing investments in manufacturing capabilities and capacity.
π The company continues to focus on delivering differentiating aerospace and defense technologies.
π Stock declined 0.98% on the day of publication, reflecting a mild negative market reaction.
Bullish Signals
$2.47 quarterly dividend shows disciplined capital allocation.
Actively investing in manufacturing capabilities and capacity.
Dividend aligns with long-term aerospace and defense purpose.
Risk Factors
Stock declined 0.98% on publication.
Heavy investment needs may limit immediate cash growth.
Bullish Signals
The $2.47 quarterly dividend demonstrates a disciplined capital allocation strategy that prioritizes returning cash to shareholders.
The company is actively investing in manufacturing capabilities and capacity to deliver advanced technologies quickly for customers.
The dividend aligns with the firm's long-term purpose of solving customers' toughest problems in aerospace and defense.
Risk Factors
Stock declined 0.98% on the day of publication, indicating a mild negative market reaction to the news.
The article notes that the company is balancing shareholder returns with heavy investment needs, which may limit immediate cash growth compared to pure yield plays.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)